Dr. Mike Apley of Kansas State University joins The Morrison Group in this At The Meeting episode, third in a series, on antibiotic resistance development, it's impact on human and animal health and the resulting stewardship debate.
At The Meeting's three part series on the impact of FDA's Guidance 209 and 213 continues. Dr. Peter Davies joins The Morrison Group to discuss the meaning of "judicious use" and it's interpretation in the U.S. and other swine producing counties.
As the industry anticipates implementation of FDA Guidance 209 and 213 on January 1, 2017, not all the answers are yet available. What we know today and how production operations will be affected is discussed on The Morrison Group's At The Meeting. Special guest Dr. Ron Prestage of Prestage Farms joins the conversation.
A new variant of Porcine Circovirus is surfacing in some operations. I asked University of Minnesota's Dr. Mike Murtaugh about the bug and how effective our current vaccines are in dealing with new entrant, PCV2d.
The National Pork Board recently underwrote a live forum put on by a division of The Atlantic Monthly magazine looking at the antibiotic use and resistance question from several perspectives. The link to the full video online at TheAtlantic.com is live. Here we share the final audio portion of the program which provides good background and food for thought.
Pork Forum 2016 coverage continues with this report to the NPPC delegates by National Pork Producers Council CEO Neil Dierks. It's about 15 minutes into the report when Dierks reviews background on the HSUS USDA Pork Trademark lawsuit and shares an interesting exchange between a legislator from North Carolina and Secretary of Agriculture Vilsack. You will want to talk with your congressman after hearing this. The Secretary later backpedaled from these recorded comments.